- Senators Barbara Boxer (D-CA) and Mark Kirk (R-IL) introduce legislation that will establish a national strategy to support regenerative medicine (RM) research.
- Among the requirements of the Regenerative Medicine Promotion Act are: a report by the GAO identifying all ongoing federal programs and activities pertaining to RM, the establishment of a Regenerative Medicine Coordinating Council and the maintenance of a national strategy for the promotion of RM R&D.
- Companies involved in the space include ONVO, HART, CUR, CYTX, STEM, ATHX.
Senators introduce regenerative medicine bill
From other sites
at CNBC.com (Dec 16, 2014)
at CNBC.com (Dec 12, 2014)
at CNBC.com (Dec 11, 2014)
at CNBC.com (Nov 18, 2014)
at CNBC.com (Oct 10, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs